HomeIXC • ASX
add
Invex Therapeutics Ltd
Previous close
$0.076
Year range
$0.060 - $0.34
Market cap
5.71M AUD
Avg Volume
6.45K
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
Market news
Financials
Income Statement
Revenue
Net income
| (AUD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 606.13K | 9,856.11% |
Operating expense | 428.27K | -81.63% |
Net income | 235.44K | 112.07% |
Net profit margin | 38.84 | 100.12% |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (AUD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 6.03M | -73.19% |
Total assets | 6.12M | -73.16% |
Total liabilities | 431.63K | -72.55% |
Total equity | 5.69M | — |
Shares outstanding | 75.15M | — |
Price to book | 0.95 | — |
Return on assets | 7.27% | — |
Return on capital | 7.82% | — |
Cash Flow
Net change in cash
| (AUD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | 235.44K | 112.07% |
Cash from operations | -63.38K | 95.71% |
Cash from investing | — | — |
Cash from financing | 0.00 | — |
Net change in cash | -63.38K | 95.71% |
Free cash flow | 120.74K | 110.30% |
About
Founded
2019
Website
